Abstract:Abstract Motivation: DNA methylation is a biological process impacting the gene functions without changing the underlying DNA sequence. The DNA methylation machinery usually attaches methyl groups to some specific cytosine residues, which modify the chromatin architectures. Such modifications in the promoter regions will inactivate some tumor-suppressor genes. DNA methylation within the coding region may significantly reduce the transcription elongation efficiency. The gene function may be tuned through some cytosines are methylated. Methods: This study hypothesizes that the overall methylation level across a gene may have a better association with the sample labels like diseases than the methylations of individual cytosines. The gene methylation level is formulated as a regression model using the methylation levels of all the cytosines within this gene. A comprehensive evaluation of various feature selection algorithms and classification algorithms is carried out between the gene-level and residue-level methylation levels. Results: A comprehensive evaluation was conducted to compare the gene and cytosine methylation levels for their associations with the sample labels and classification performances. The unsupervised clustering was also improved using the gene methylation levels. Some genes demonstrated statistically significant associations with the class label, even when no residue-level methylation features have statistically significant associations with the class label. So in summary, the trained gene methylation levels improved various methylome-based machine learning models. Both methodology development of regression algorithms and experimental validation of the gene-level methylation biomarkers are worth of further investigations in the future studies. The source code, example data files and manual are available at http://www.healthinformaticslab.org/supp/.

DiseaseMeth Version 2.0: a Major Expansion and Update of the Human Disease Methylation Database

DiseaseMeth version 3.0: a major expansion and update of the human disease methylation database

Diseasemeth: A Human Disease Methylation Database

MethHC 2.0: information repository of DNA methylation and gene expression in human cancer

MethyCancer: the Database of Human DNA Methylation and Cancer

MethBank 4.0: an updated database of DNA methylation across a variety of species

MethBank 3.0: a database of DNA methylomes across a variety of species

SurvivalMeth: a web server to investigate the effect of DNA methylation-related functional elements on prognosis

HMDD V2.0: a Database for Experimentally Supported Human Microrna and Disease Associations

Wemics: A Single‐Base Resolution Methylation Quantification Method for Enhanced Prediction of Epigenetic Regulation

MethMarkerDB: a comprehensive cancer DNA methylation biomarker database

CanMethdb: a database for genome-wide DNA methylation annotation in cancers

The Progress on the Estimation of DNA Methylation Level and the Detection of Abnormal Methylation

A comprehensive comparison of residue-level methylation levels with the regression-based gene-level methylation estimations by ReGear

CancerMHL: the database of integrating key DNA methylation, histone modifications and lncRNAs in cancer

ImmuMethy, a database of DNA methylation plasticity at a single cytosine resolution in human blood and immune cells.

HMDD v3.0: a database for experimentally supported human microRNA–disease associations

ASMdb: a comprehensive database for allele-specific DNA methylation in diverse organisms

DNMIVD: DNA Methylation Interactive Visualization Database

Predict disease-related RNA methylation sites from the methylation-expression association by using hypergeometric test

Methylomics and cancer: the current state of methylation profiling and marker development for clinical care